Autonomic Dysreflexia: Current Pharmacologic Management.

As of 2023, US-based physicians caring for individuals with SCI largely have formal inpatient protocols in place for medication management of AD, with nearly all relying on nitroglycerin ointment as their first line medication. In areas outside of the US where nitroglycerin ointment is unavailable, pharmacologic practice patterns significantly differ. This article is protected by copyright. All rights reserved.